Overview


According to FutureWise analysis the market for mri-safe neurostimulation systems in 2026 is US$ 0.45 billion, and is expected to reach US$ 1.37 billion by 2036 at a CAGR of 11.78%. MRI-safe neurostimulation systems enable patients with implanted devices, like spinal cord or deep brain stimulators, to safely undergo MRI scans without risk of device malfunction. These systems use specialized materials and shielding to prevent heating, movement, or interference. The increasing adoption of implantable neuromodulation therapies and the demand for diagnostic imaging are driving market growth.

MRI-safe neurostimulation systems represent a significant advancement in the field of implantable medical devices, specifically designed to provide therapeutic electrical stimulation to targeted nerves or regions of the brain while ensuring safety during magnetic resonance imaging (MRI) procedures. These devices are widely utilized in the management of chronic pain, Parkinson’s disease, epilepsy, essential tremor, dystonia, and various other neurological disorders.

Historically, patients with implanted neurostimulation devices faced numerous challenges when requiring MRI scans. Concerns included the potential for heating of leads, device malfunction, unintended stimulation, or movement induced by strong magnetic fields. To address these issues, MRI-safe systems have been developed, allowing patients to benefit from essential diagnostic imaging without the associated risks.

Typically, neurostimulation systems consist of implanted electrodes (leads), an implantable pulse generator (IPG), and an external programmer. In the design of MRI-safe devices, care is taken to use non-ferromagnetic materials and to implement advanced insulation and shielding technologies that minimize magnetic interference. Moreover, these systems often incorporate specific programming modes that enable safe adjustments or temporary modifications before undergoing an MRI scan, ensuring adherence to safety protocols.

The increasing prevalence of chronic neurological conditions and the growing acceptance of neuromodulation therapies have significantly contributed to the demand for MRI-safe systems. Many patients with implanted devices require regular imaging for monitoring their conditions or evaluating other health issues, making MRI compatibility an essential consideration in device selection. Healthcare providers are increasingly inclined to opt for MRI-conditional or MRI-safe neurostimulation devices to guarantee greater diagnostic flexibility over time.

Continuous technological advancements are leading to improvements in device miniaturization, battery life, wireless programming capabilities, and overall patient comfort, thereby expanding the clinical applications of these systems. As the focus shifts towards precision medicine and patient-centered care, MRI-safe neurostimulation systems play a crucial role in integrating therapeutic innovation with diagnostic accessibility, thereby ensuring the continuity of treatment alongside imaging safety in contemporary healthcare environments.

FutureWise Market Research has instantiated a report that provides an intricate analysis of MRI-Safe Neurostimulation Systems Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the MRI-Safe Neurostimulation Systems Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Medtronic Inc.
  • Cyberonics, Inc.
  • AADCO Medical Inc.
  • Boston Scientific
  • Sorin
  • St. Jude Medical
  • Biotronik

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type

  • Implantable MRI-Safe Neurostimulators
  • Transcutaneous MRI-Safe Neurostimulators

By Application Type

  • Spinal Cord Stimulation (SCS)
  • Peripheral Nerve Stimulation
  • Intracranial Stimulation
  • Deep Brain Stimulation
  • Motor Cortex Stimulation
  • Sensory Nerve Stimulation
  • Vagus Nerve Stimulation

By End User Type

  • Hospitals and Clinics
  • Diagnostic Labs and Centers
  • Ambulatory Surgical Centers
  • Research Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the MRI-Safe Neurostimulation Systems Market By Product Type, By Application Type, By End User Type and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   MRI-Safe Neurostimulation Systems Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of MRI-Safe Neurostimulation Systems Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   MRI-Safe Neurostimulation Systems Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   MRI-Safe Neurostimulation Systems Market, By Product Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Implantable MRI-Safe Neurostimulators
        2. Transcutaneous MRI-Safe Neurostimulators

  • 8.   MRI-Safe Neurostimulation Systems Market, By Application Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Spinal Cord Stimulation (SCS)
        2. Peripheral Nerve Stimulation
        3. Intracranial Stimulation
        4. Deep Brain Stimulation
        5. Motor Cortex Stimulation
        6. Sensory Nerve Stimulation
        7. Vagus Nerve Stimulation

  • 9.   MRI-Safe Neurostimulation Systems Market, By End User Type Historical Analysis and Forecast 2026-2036 (USD Million)
    •   1. Hospitals and Clinics
        2. Diagnostic Labs and Centers
        3. Ambulatory Surgical Centers
        4. Research Laboratories

  • 10.   North America MRI-Safe Neurostimulation Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2026-2036

  • 11.   Latin America MRI-Safe Neurostimulation Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2026-2036

  • 12.   Europe MRI-Safe Neurostimulation Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2026-2036

  • 13.   Asia Pacific MRI-Safe Neurostimulation Systems Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2026-2036

  • 14.   Middle East and Africa Market Analysis 2019-2025 and Forecast 2026-2036 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2019-2025
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2026-2036

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Cyberonics, Inc.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. AADCO Medical Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Boston Scientific
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sorin
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. St. Jude Medical
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Biotronik
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients